Search

Search Results
Results 18301 - 18310 of 18490 for stroke
  • Nationwide alert on tainted weight loss products
    News - 22 Mar 2009
    The U.S. Food and Drug Administration is expanding, for the second time, its nationwide alert to consumers about tainted weight loss products containing
  • Nolvadex
    Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Nolvadex (Tamoxifen citrate) intended for persons living in Australia.
  • Hydopa
    Drug - 20 Aug 2024
    Consumer Medicine Information (CMI) about Hydopa (methyldopa) intended for persons living in Australia.
  • Alphapress
    Drug - 29 Jul 2024
    Consumer Medicine Information (CMI) about Alphapress (hydralazine hydrochloride) intended for persons living in Australia.
  • Lipigem
    Drug - 6 Jun 2024
    Consumer Medicine Information (CMI) about Lipigem (gemfibrozil) intended for persons living in Australia.
  • Bicillin L-A
    Drug - 3 Apr 2024
    Consumer Medicine Information (CMI) about Bicillin L-A (benzathine benzylpenicillin tetrahydrate) intended for persons living in Australia.
  • Duavive
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Duavive (Conjugated estrogens/bazedoxifene) intended for persons living in Australia.
  • Depo-Nisolone
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Depo-Nisolone (methylprednisolone acetate) intended for persons living in Australia.
  • Depo-Medrol
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Depo-Medrol (methylprednisolone acetate) intended for persons living in Australia.
  • Zomig
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zomig (Zolmitriptan) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback